Intraocular Lymphoma

Intraocular lymphoma, a rare form of cancer affecting the eyes, presents a unique challenge in cancer research due to its rarity and complexity. This malignancy primarily involves the lymphocytes within the eye, often mimicking other ocular conditions, leading to misdiagnosis and delayed treatment. Current research efforts focus on elucidating the underlying molecular mechanisms driving intraocular lymphoma development and progression, as well as refining diagnostic methods for early detection. Immunotherapies, such as monoclonal antibodies and CAR-T cell therapy, are being explored as promising treatment modalities to target specific antigens expressed by lymphoma cells. Collaborative efforts between oncologists, ophthalmologists, and researchers aim to improve patient outcomes by advancing our understanding of intraocular lymphoma and developing more effective therapeutic strategies.